{
  "spec_version": "3",
  "endpoint": "decisions",
  "stock_code": "4967",
  "company_name": "小林製薬",
  "content_lang": "ja",
  "meta_lang": "en",
  "canonical_url": "https://the-shashi.com/tse/4967/",
  "api_url": "/api/4967/decisions.json",
  "updated": "2026-08-05",
  "license": "© 2026 Yutaka Sugiura. All rights reserved.",
  "attribution": "The社史 (the-shashi.com) — https://the-shashi.com/tse/4967/",
  "count": 2,
  "description": "Index of this company's management decisions. One decision = one endpoint: follow api_url for the full dossier (background, the decision itself, outcome, quoted primary sources and references).",
  "decisions": [
    {
      "slug": "beni-koji-scandal-2024",
      "url": "/tse/4967/decisions/beni-koji-scandal-2024/",
      "api_url": "/api/4967/decisions/beni-koji-scandal-2024.json",
      "year": 2024,
      "month": 7,
      "type": "governance",
      "title": "紅麹サプリ健康被害の引責と創業家経営陣の退任・統治刷新",
      "subtitle": "死者を出した危機対応の遅れを、創業家はどう引き取り、統治をどう作り替えたか",
      "status": "implemented",
      "status_label": "実施"
    },
    {
      "slug": "oasis-kobayashi-pharma-2026",
      "url": "/tse/4967/decisions/oasis-kobayashi-pharma-2026/",
      "api_url": "/api/4967/decisions/oasis-kobayashi-pharma-2026.json",
      "year": 2026,
      "month": 2,
      "type": "shareholder_proposal",
      "tags": [
        "cp-activist",
        "gv-family",
        "gv-board"
      ],
      "title": "オアシスの統治改革要求への対応と監査等委員会設置会社への移行",
      "subtitle": "脱・創業家依存は誰の手で進めるのか——紅麹問題後の統治をめぐる筆頭株主との攻防",
      "status": "implemented",
      "status_label": "実施"
    }
  ],
  "by_type": [
    {
      "key": "governance",
      "count": 1,
      "url": "/api/4967/decisions/by-type/governance.json"
    },
    {
      "key": "shareholder_proposal",
      "count": 1,
      "url": "/api/4967/decisions/by-type/shareholder_proposal.json"
    }
  ],
  "by_decade": [
    {
      "key": "2020s",
      "count": 2,
      "url": "/api/4967/decisions/by-decade/2020s.json"
    }
  ]
}